Abstract

Recently, the Mucin-1 (MUC1) gene has been identified as a causal gene of autosomal dominant tubulointerstitial kidney disease (ADTKD). Most causative mutations are buried within a GC-rich 60 basepair variable number of tandem repeat (VNTR), which escapes identification by massive parallel sequencing methods due to the complexity of the VNTR. We established long read single molecule real time sequencing (SMRT) targeted to the MUC1-VNTR as an alternative strategy to the snapshot assay. Our approach allows complete VNTR assembly, thereby enabling the detection of all variants residing within the VNTR and simultaneous determination of VNTR length. We present high resolution data on the VNTR architecture for a cohort of snapshot positive (n = 9) and negative (n = 7) ADTKD families. By SMRT sequencing we could confirm the diagnosis in all previously tested cases, reconstruct both VNTR alleles and determine the exact position of the causative variant in eight of nine families. This study demonstrates that precise positioning of the causative mutation(s) and identification of other coding and noncoding sequence variants in ADTKD-MUC1 is feasible. SMRT sequencing could provide a powerful tool to uncover potential factors encoded within the VNTR that associate with intra- and interfamilial phenotype variability of MUC1 related kidney disease.

Details

Title
Single molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations
Author
Wenzel, Andrea 1 ; Altmueller, Janine 2 ; Ekici, Arif B 3   VIAFID ORCID Logo  ; Popp, Bernt 3   VIAFID ORCID Logo  ; Stueber, Kurt 4 ; Thiele, Holger 5 ; Pannes, Alois 6 ; Staubach, Simon 7 ; Salido, Eduardo 8 ; Nuernberg, Peter 5 ; Reinhardt, Richard 4 ; Reis, André 3   VIAFID ORCID Logo  ; Rump, Patrick 9   VIAFID ORCID Logo  ; Franz-Georg Hanisch 10 ; Wolf, Matthias T F 11 ; Wiesener, Michael 12 ; Huettel, Bruno 4 ; Beck, Bodo B 1 

 Institute of Human Genetics, University Hospital of Cologne, Cologne, Germany 
 Institute of Human Genetics, University Hospital of Cologne, Cologne, Germany; Cologne Center for Genomics (CCG) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany 
 Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany 
 The Max Planck-Genome-Centre Cologne (MP-GC), Max Planck Institute for Plant Breeding Research, Carl-von-Linné-Weg 10, Cologne, Germany 
 Cologne Center for Genomics (CCG) and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany 
 Unaffiliated, Huerth, Germany 
 Institute of Human Genetics, University Hospital of Cologne, Cologne, Germany; Institute of Biochemistry II, Medical Faculty, University of Cologne, Cologne, Germany 
 Pathology Department Universidad de La Laguna, Hospital Universitario de Canarias Ofra s/n, La Laguna, Tenerife, Spain 
 Department of Genetics, Clinical Genetics Section University Medical Center Groningen, Groningen, The Netherlands 
10  Institute of Biochemistry II, Medical Faculty, University of Cologne, Cologne, Germany 
11  Pediatric Nephrology, University of Texas Southwestern Medical Center, Dallas, TX, USA 
12  Department of Nephrology and Hypertension, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany 
Pages
1-12
Publication year
2018
Publication date
Mar 2018
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2012136668
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.